These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8519823)

  • 1. [Cefpodoxime].
    Enferm Infecc Microbiol Clin; 1995; 13(7):437-8. PubMed ID: 8519823
    [No Abstract]   [Full Text] [Related]  

  • 2. Cefpodoxime proxetil--a new oral cephalosporin.
    Med Lett Drugs Ther; 1992 Nov; 34(884):107-8. PubMed ID: 1435506
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical evaluation of cefpodoxime proxetil in patients with dermatological infections.
    Imaizumi T; Ishikawa H; Hashimoto I
    J Chemother; 1995 Nov; 7 Suppl 4():137-41. PubMed ID: 8904135
    [No Abstract]   [Full Text] [Related]  

  • 4. Microbiological and clinical studies on cefpodoxime proxetil for bacterial skin and soft tissue infections in pediatric patients.
    Ito K; Ito M
    J Chemother; 1995 Nov; 7 Suppl 4():124-6. PubMed ID: 8904131
    [No Abstract]   [Full Text] [Related]  

  • 5. [Reevaluation of current antimicrobials. Cefpodoxime proxetil. Discussion].
    Jpn J Antibiot; 1995 Feb; 48(2):183-90. PubMed ID: 7745807
    [No Abstract]   [Full Text] [Related]  

  • 6. [(New antimicrobial agent series XLIV): cefpodoxime proxetil].
    Kumazawa J
    Jpn J Antibiot; 1993 Sep; 46(9):749-72. PubMed ID: 8254896
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical evaluation of cefpodoxime proxetil dry syrup in pediatric cutaneous bacterial infection.
    Terui T; Tagami H
    J Chemother; 1995 Nov; 7 Suppl 4():119-21. PubMed ID: 8904129
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of cefpodoxime proxetil dry syrup in pediatric patients with various infections.
    Muranaka H; Yokoyama M
    J Chemother; 1995 Nov; 7 Suppl 4():127-30. PubMed ID: 8904132
    [No Abstract]   [Full Text] [Related]  

  • 9. A multi-institutional study on clinical effectiveness of cefpodoxime proxetil dry syrup in childhood infections.
    Imanaka H; Kitahara T; Yoshinaga M; Miyata K
    J Chemother; 1995 Nov; 7 Suppl 4():131-3. PubMed ID: 8904133
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetic-pharmacodynamic modelling of antibacterial activity of cefpodoxime and cefixime in in vitro kinetic models.
    Liu P; Rand KH; Obermann B; Derendorf H
    Int J Antimicrob Agents; 2005 Feb; 25(2):120-9. PubMed ID: 15664481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefpodoxime proxetil.
    Del Beccaro MA
    Pediatr Ann; 1993 Mar; 22(3):187-92, 195-6. PubMed ID: 8464650
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical studies of cefpodoxime proxetil in pediatric field].
    Kimura S; Yokoyama M; Kudo M; Aoyama R; Okamoto T; Tsushima N; Onodera N; Ikeda Y
    Jpn J Antibiot; 1989 Jul; 42(7):1477-87. PubMed ID: 2810724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of cefpodoxime against bacterial isolates obtained from patients with cancer.
    Rolston KV; Messer M; Nguyen H; Ho D; LeBlanc B; Bodey GP
    Eur J Clin Microbiol Infect Dis; 1991 Jul; 10(7):581-5. PubMed ID: 1915401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of cefpodoxime proxetil on the treatment of bacterial infections].
    Li JT; Hou J; Kao L
    Zhonghua Nei Ke Za Zhi; 1994 Jul; 33(7):440-3. PubMed ID: 7867436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro activity of cefpodoxime proxetil (RU 51807): a comparative disk diffusion study on isolates from geriatric patients.
    Ottomano C; Frugoni S; Berlusconi A; Miseferi G; Mattina R; Anelli M
    J Chemother; 1991 Jan; 3 Suppl 1():62-5. PubMed ID: 12041788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of correlation between in vitro susceptibility data of anaerobes to ceftizoxime and clinical response.
    Wikler MA; Moonsammy GI; Nichols RL
    J Chemother; 1989 Jul; 1(4 Suppl):660-1. PubMed ID: 16312580
    [No Abstract]   [Full Text] [Related]  

  • 17. Activity of cefpodoxime, an oral 3rd generation cephalosporin.
    Raymond N; Lang S
    N Z Med J; 1993 Feb; 106(949):44. PubMed ID: 8464593
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trials of cefpodoxime proxetil suspension in paediatrics.
    Fujii R
    Drugs; 1991; 42 Suppl 3():57-60. PubMed ID: 1726209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antimicrobial activities of lactoferrin, its concomitant use with cefpodoxime proxetil and clinical effect of cefpodoxime proxetil.
    Chimura T; Hirayama T; Nakahara M
    Jpn J Antibiot; 1993 Jun; 46(6):482-5. PubMed ID: 8360983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of cefpodoxime proxetil in otorhinolaryngological infections].
    Takeuchi H; Ikoma H; Suzuki T; Nakajima M; Kouzaki Y; Ishizu Y; Makino H; Sugihara S; Ootawara S; Asagi K
    Jpn J Antibiot; 1994 Jan; 47(1):84-92. PubMed ID: 8114275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.